UniProt ID | CLUS_MOUSE | |
---|---|---|
UniProt AC | Q06890 | |
Protein Name | Clusterin | |
Gene Name | Clu | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 448 | |
Subcellular Localization |
Secreted . Nucleus . Cytoplasm . Mitochondrion membrane Peripheral membrane protein Cytoplasmic side. Cytoplasm, cytosol . Microsome. Endoplasmic reticulum. Cytoplasmic vesicle, secretory vesicle, chromaffin granule. Can retrotranslocate from the s |
|
Protein Description | Functions as extracellular chaperone that prevents aggregation of nonnative proteins. Prevents stress-induced aggregation of blood plasma proteins. Inhibits formation of amyloid fibrils by APP, APOC2, B2M, CALCA, CSN3, SNCA and aggregation-prone LYZ variants (in vitro). Does not require ATP. Maintains partially unfolded proteins in a state appropriate for subsequent refolding by other chaperones, such as HSPA8/HSC70. Does not refold proteins by itself. Binding to cell surface receptors triggers internalization of the chaperone-client complex and subsequent lysosomal or proteasomal degradation. When secreted, protects cells against apoptosis and against cytolysis by complement. Intracellular forms interact with ubiquitin and SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complexes and promote the ubiquitination and subsequent proteasomal degradation of target proteins. Promotes proteasomal degradation of COMMD1 and IKBKB. Modulates NF-kappa-B transcriptional activity. Promotes apoptosis when in the nucleus. Inhibits apoptosis when associated with the mitochondrial membrane by interference with BAX-dependent release of cytochrome c into the cytoplasm. Plays a role in the regulation of cell proliferation (By similarity).. | |
Protein Sequence | MKILLLCVALLLIWDNGMVLGEQEVSDNELQELSTQGSRYINKEIQNAVQGVKHIKTLIEKTNAERKSLLNSLEEAKKKKEDALEDTRDSEMKLKAFPEVCNETMMALWEECKPCLKHTCMKFYARVCRSGSGLVGQQLEEFLNQSSPFYFWMNGDRIDSLLESDRQQSQVLDAMQDSFARASGIIDTLFQDRFFARELHDPHYFSPIGFPHKRPHFLYPKSRLVRSLMSPSHYGPPSFHNMFQPFFEMIHQAQQAMDVQLHSPAFQFPDVDFLREGEDDRTVCKEIRRNSTGCLKMKGQCEKCQEILSVDCSTNNPAQANLRQELNDSLQVAERLTEQYKELLQSFQSKMLNTSSLLEQLNDQFNWVSQLANLTQGEDKYYLRVSTVTTHSSDSEVPSRVTEVVVKLFDSDPITVVLPEEVSKDNPKFMDTVAEKALQEYRRKSRAE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
102 | N-linked_Glycosylation | KAFPEVCNETMMALW HHHHHHHHHHHHHHH | 53.61 | - | |
132 | Phosphorylation | ARVCRSGSGLVGQQL HHHHHCCCCHHHHHH | 30.15 | - | |
144 | N-linked_Glycosylation | QQLEEFLNQSSPFYF HHHHHHHHCCCCEEE | 45.04 | - | |
160 | Phosphorylation | MNGDRIDSLLESDRQ ECCHHHHHHHHHHHH | 32.27 | - | |
188 | Phosphorylation | RASGIIDTLFQDRFF HHHCHHHHHHHCHHH | 21.04 | 27180971 | |
206 | Phosphorylation | LHDPHYFSPIGFPHK CCCCCCCCCCCCCCC | 14.40 | 24719451 | |
290 | N-linked_Glycosylation | VCKEIRRNSTGCLKM HHHHHHHCCCCCCEE | 33.79 | 17330941 | |
327 | N-linked_Glycosylation | ANLRQELNDSLQVAE HHHHHHHHHHHHHHH | 35.75 | 16944957 | |
341 | Ubiquitination | ERLTEQYKELLQSFQ HHHHHHHHHHHHHHH | 41.39 | 22790023 | |
353 | N-linked_Glycosylation | SFQSKMLNTSSLLEQ HHHHCCCCHHHHHHH | 34.12 | - | |
373 | N-linked_Glycosylation | NWVSQLANLTQGEDK CHHHHHHCCCCCCCC | 52.81 | - | |
386 | Phosphorylation | DKYYLRVSTVTTHSS CCEEEEEEEEEECCC | 15.66 | 29472430 | |
387 | Phosphorylation | KYYLRVSTVTTHSSD CEEEEEEEEEECCCC | 21.00 | 29472430 | |
389 | Phosphorylation | YLRVSTVTTHSSDSE EEEEEEEEECCCCCC | 20.91 | 29472430 | |
390 | Phosphorylation | LRVSTVTTHSSDSEV EEEEEEEECCCCCCC | 18.54 | 29472430 | |
392 | Phosphorylation | VSTVTTHSSDSEVPS EEEEEECCCCCCCCC | 33.48 | 24719451 | |
393 | Phosphorylation | STVTTHSSDSEVPSR EEEEECCCCCCCCCC | 37.24 | 24719451 | |
395 | Phosphorylation | VTTHSSDSEVPSRVT EEECCCCCCCCCCCE | 42.30 | 29472430 | |
399 | Phosphorylation | SSDSEVPSRVTEVVV CCCCCCCCCCEEEHH | 44.55 | 29472430 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CLUS_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CLUS_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CLUS_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HYALP_MOUSE | Spam1 | physical | 19357365 | |
LEP_MOUSE | Lep | physical | 12824284 | |
VLDLR_HUMAN | VLDLR | physical | 12824284 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides."; Bernhard O.K., Kapp E.A., Simpson R.J.; J. Proteome Res. 6:987-995(2007). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-290, AND MASSSPECTROMETRY. | |
"Proteome-wide characterization of N-glycosylation events by diagonalchromatography."; Ghesquiere B., Van Damme J., Martens L., Vandekerckhove J.,Gevaert K.; J. Proteome Res. 5:2438-2447(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-327, AND MASSSPECTROMETRY. |